172 related articles for article (PubMed ID: 2999573)
1. Serum interferon and clinical manifestations of infection with human T-lymphotropic virus type III.
Abb J
Med Microbiol Immunol; 1985; 174(4):205-10. PubMed ID: 2999573
[TBL] [Abstract][Full Text] [Related]
2. Prospective study of cytotoxic T lymphocyte responses to influenza and antibodies to human T lymphotropic virus-III in homosexual men. Selective loss of an influenza-specific, human leukocyte antigen-restricted cytotoxic T lymphocyte response in human T lymphotropic virus-III positive individuals with symptoms of acquired immunodeficiency syndrome and in a patient with acquired immunodeficiency syndrome.
Shearer GM; Salahuddin SZ; Markham PD; Joseph LJ; Payne SM; Kriebel P; Bernstein DC; Biddison WE; Sarngadharan MG; Gallo RC
J Clin Invest; 1985 Oct; 76(4):1699-704. PubMed ID: 2997287
[TBL] [Abstract][Full Text] [Related]
3. Prevalence of antibody to human T-lymphotropic virus type III in AIDS and AIDS-risk patients in Britain.
Cheingsong-Popov R; Weiss RA; Dalgleish A; Tedder RS; Shanson DC; Jeffries DJ; Ferns RB; Briggs EM; Weller IV; Mitton S
Lancet; 1984 Sep; 2(8401):477-80. PubMed ID: 6147546
[TBL] [Abstract][Full Text] [Related]
4. Seroepidemiological studies of human T-lymphotropic retrovirus type III in acquired immunodeficiency syndrome.
Safai B; Sarngadharan MG; Groopman JE; Arnett K; Popovic M; Sliski A; Schüpbach J; Gallo RC
Lancet; 1984 Jun; 1(8392):1438-40. PubMed ID: 6145881
[TBL] [Abstract][Full Text] [Related]
5. Determinants of retrovirus (HTLV-III) antibody and immunodeficiency conditions in homosexual men.
Goedert JJ; Sarngadharan MG; Biggar RJ; Weiss SH; Winn DM; Grossman RJ; Greene MH; Bodner AJ; Mann DL; Strong DM
Lancet; 1984 Sep; 2(8405):711-6. PubMed ID: 6148471
[TBL] [Abstract][Full Text] [Related]
6. Serum beta 2-microglobulin and interferon in homosexual males: relationship to clinical findings and serologic status to the human T lymphotropic virus (HTLV-III).
Calabrese LH; Proffitt MR; Gupta MK; Easley KA; Walker JR; Rehm SJ; Valenzuela R; Clough JD
AIDS Res; 1984-1985; 1(6):423-38. PubMed ID: 6085927
[TBL] [Abstract][Full Text] [Related]
7. Seroepidemiology of human T-lymphotropic virus type III among homosexual men with the acquired immunodeficiency syndrome or generalized lymphadenopathy and among asymptomatic controls in Boston.
Groopman JE; Mayer KH; Sarngadharan MG; Ayotte D; Devico AL; Finberg R; Sliski AH; Allan JD; Gallo RC
Ann Intern Med; 1985 Mar; 102(3):334-7. PubMed ID: 2982305
[TBL] [Abstract][Full Text] [Related]
8. Antibodies to human T lymphotropic virus type III demonstrated by a dot immunobinding assay.
Biberfeld G; Bredberg-Råden U; Böttiger B; Biberfeld P; Morfeldt-Månsson L; Suni J; Vaheri A; Saxinger C; Gallo R
Scand J Immunol; 1985 Mar; 21(3):289-92. PubMed ID: 2986278
[TBL] [Abstract][Full Text] [Related]
9. IgM and IgG antibodies to human T cell lymphotropic retrovirus (HTLV-III) in lymphadenopathy syndrome and subjects at risk for AIDS in Italy.
Aiuti F; Rossi P; Sirianni MC; Carbonari M; Popovic M; Sarngadharan MG; Contu L; Moroni M; Romagnani S; Gallo RC
Br Med J (Clin Res Ed); 1985 Jul; 291(6489):165-6. PubMed ID: 2990634
[TBL] [Abstract][Full Text] [Related]
10. Antibody to human T cell leukaemia virus type III in Australian homosexual men with lymphadenopathy.
Frazer IH; Sarngadharan MG; Mackay IR; Gallo RC
Med J Aust; 1984 Sep; 141(5):274-6. PubMed ID: 6088957
[TBL] [Abstract][Full Text] [Related]
11. Low prevalence in the UK of HTLV-I and HTLV-II infection in subjects with AIDS, with extended lymphadenopathy, and at risk of AIDS.
Tedder RS; Shanson DC; Jeffries DJ; Cheingsong-Popov R; Clapham P; Dalgleish A; Nagy K; Weiss RA
Lancet; 1984 Jul; 2(8395):125-8. PubMed ID: 6146034
[TBL] [Abstract][Full Text] [Related]
12. Relation of HTLV-III seropositivity and lymphadenopathy.
Jeffries E; Boyko WJ; Willoughby B; Constance PD; Wiggs B; O'Shaughnessy M; Sharp FR
Can Med Assoc J; 1985 Jul; 133(2):111-2. PubMed ID: 2988732
[TBL] [Abstract][Full Text] [Related]
13. IgG-antibodies to HTLV-III in patients with AIDS, LAS, and persons at risk of AIDS in West Germany.
Hehlmann R; Kreeb G; Erfle V; Piechowiak H; Krüger G; Goebel FD
Blut; 1985 Jan; 50(1):13-8. PubMed ID: 2981593
[TBL] [Abstract][Full Text] [Related]
14. Diversity of clinical spectrum of HTLV-III infection.
Valle SL; Saxinger C; Ranki A; Antonen J; Suni J; Lähdevirta J; Krohn K
Lancet; 1985 Feb; 1(8424):301-4. PubMed ID: 2857362
[TBL] [Abstract][Full Text] [Related]
15. Human T-cell lymphotropic virus type III associated disorders. The spectrum in the heterosexual population.
Gill PS; Levine AM; Meyer PR; Aguilar SL; Rarick M; Parker JW; Rasheed S
Arch Intern Med; 1986 Aug; 146(8):1501-4. PubMed ID: 3015064
[TBL] [Abstract][Full Text] [Related]
16. HTLV-I-specific antibody in AIDS patients and others at risk.
Robert-Guroff M; Blayney DW; Safai B; Lange M; Gelmann EP; Gutterman JW; Mansell PW; Goedert JL; Groopman JE; Steigbigel NH
Lancet; 1984 Jul; 2(8395):128-31. PubMed ID: 6146035
[TBL] [Abstract][Full Text] [Related]
17. Immunological and virological investigation in patients with lymphoadenopathy syndrome and in a population at risk for acquired immunodeficiency syndrome (AIDS), with particular focus on the detection of antibodies to human T-lymphotropic retroviruses (HTLV III).
Sirianni MC; Rossi P; Scarpati B; Ragona G; Seminara R; Bonomo G; Aiuti F
J Clin Immunol; 1985 Jul; 5(4):261-8. PubMed ID: 2995433
[TBL] [Abstract][Full Text] [Related]
18. Antibody seronegative human T-lymphotropic virus type III (HTLV-III)-infected patients with acquired immunodeficiency syndrome or related disorders.
Groopman JE; Hartzband PI; Shulman L; Salahuddin SZ; Sarngadharan MG; McLane MF; Essex M; Gallo R
Blood; 1985 Sep; 66(3):742-4. PubMed ID: 2992644
[TBL] [Abstract][Full Text] [Related]
19. Virus-neutralizing activity, serologic heterogeneity, and retrovirus isolation from homosexual men in the Los Angeles area.
Rasheed S; Norman GL; Gill PS; Meyer PR; Cheng L; Levine AM
Virology; 1986 Apr; 150(1):1-9. PubMed ID: 3006329
[TBL] [Abstract][Full Text] [Related]
20. Persistent infection with human T-lymphotropic virus type III/lymphadenopathy-associated virus in apparently healthy homosexual men.
Jaffe HW; Feorino PM; Darrow WW; O'Malley PM; Getchell JP; Warfield DT; Jones BM; Echenberg DF; Francis DP; Curran JW
Ann Intern Med; 1985 May; 102(5):627-8. PubMed ID: 2984973
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
